|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 25 MASSACHUSETTS AVENUE, NW |
Address2 | SUITE 600 |
City | WASHINGTON |
State | DC |
Zip Code | 20001-7400 |
Country | USA |
3. Principal place of business (if different than line 2)
City | Chicago |
State | IL |
Zip Code | 60611-5885 |
Country | USA |
|
5. Senate ID# 2877-12
|
||||||||
|
6. House ID# 304640000
|
TYPE OF REPORT | 8. Year | 2017 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: George E. Cox III, JD |
Date | 1/22/2018 12:25:20 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 4667, Making further supplemental appropriations for the fiscal year ending September 30, 2018, for disaster assistance for Hurricanes Harvey, Irma, and Maria, and calendar year 2017 wildfires, and for other purposes, all provisions
FY 2018 Appropriations, provisions relating to FDA tobacco products oversight authority
Funding for Comprehensive Addiction and Recovery Act (CARA)
Funding for Cost-sharing Reductions (CSRs)
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Andrew |
Wankum |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code EDU
16. Specific lobbying issues
H.R. 1, Tax Cut and Jobs Act, provisions relating to student loan interest and debt forgiveness, and taxation of graduate school tuition waivers
H.R. 4508, Promoting Real Opportunity, Success, and Prosperity through Education Reform PROSPER) Act, all provisions
Title VII Health Professions Workforce Programs Reauthorization/pediatric subspecialties student loan repayment
Public Service Loan Forgiveness (PSLF)
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE, Education - Dept of
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Jason |
Marino |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 1, Tax Cut and Jobs Act, provisions relating to medical expense deductions, and ACA insurance mandate
S. 1803, Marijuana Effective Drug Studies (MEDS) Act of 2017, all provisions
H.R. 3528, Every Prescription Conveyed Securely Act, all provisions
H.R. 394, Restoring Access to Medication Act of 2017, all provisions
S. 85, Restoring Access to Medication Act of 2017, all provisions
S. 2135, Fix NICS Act of 2017, all provisions
H.R. 3928, Truth in Healthcare Marketing Act of 2017, all provisions
H.R. 3767, Ensuring Children's Access to Specialty Care Act of 2017, all provisions
S. 989, Ensuring Children's Access to Specialty Care Act of 2017, all provisions
42 CFR Part 2, Privacy of substance abuse treatment records
American Health Care Act (AHCA), all provisions
Better Care Reconciliation Act (BCRA), all provisions
Individual health insurance mandate repeal
Healthcare system reform
Opioid Abuse
Continuing Medical Education (CME) and opioid/pain management prescribing
Drug price transparency
Regulatory Relief
Prediabetes and hypertension
Cybersecurity
Digital health
In-office compounding
Cost-sharing Reduction Payments (CSR)
Deferred Action for Childhood Arrivals (DACA)
Health Savings Accounts - Prescription requirement for over-the-counter medications
Telemedicine
Electronic Health Records (EHR)
EHR - Data Blocking/Interoperability
CDCs FY19 Budget language censorship
Solo/small practice physician groups
Broadband coverage expansion into rural communities/National Service Fund cap
Gun violence
Nutrition Facts Label Regulations
Supplemental Nutrition Assistance Program (SNAP)
Physician Innovation Network and Integrated Health Model Initiative
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Federal Trade Commission (FTC), Health & Human Services - Dept of (HHS), Agriculture - Dept of (USDA), Food & Drug Administration (FDA), Federal Communications Commission (FCC), Justice - Dept of (DOJ)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Matthew |
Reid |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Sylvia |
Trujillo |
|
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code IND
16. Specific lobbying issues
Indian Health Service
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Dana |
Lichtenberg |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
S. 898, Conrad State 30 and Physician Access Reauthorization Act, all provisions
Medical Licensure
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Jason |
Marino |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
S. 1016, CONNECT for Health Act of 2017, provisions relating to telehealth
S. 870, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act of 2017, all provisions
H.R. 1017, Removing Barriers to Colorectal Cancer Screening Act of 2017, all provisions
S. 479, Removing Barriers to Colorectal Cancer Screening Act of 2017, all provisions
H.R. 4206, Medicare Care Coordination Improvement Act of 2017, all provisions
S. 2051, Medicare Care Coordination Improvement Act of 2017, all provisions
H.R. 3922, Continuing Community Health And Medical Professional Programs to Improve Our Nation, Increase National Gains, and Help Ensure Access for Little Ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable (CHAMPIONING HEALTHY KIDS) Act of 2017, all provisions
H.R. 3120, To amend title XVIII of the Social Security Act to reduce the volume of future electronic health record-related significant hardship requests, all provisions
H.R. 849, Protecting Seniors Access to Medicare Act, all provisions
S. 2059, EHR Regulatory Relief Act, all provisions
H.R. 6101, ACO Improvement Act of 2016, all provisions
H.R. 4005, Medicaid Reentry Act, all provisions
H.R. 4097, Medicare Beneficiary Opioid Addiction Treatment Act, all provisions
Medicare program: Creating Access to Residency Education Act, all provisions
Medicare program: Protecting Access to Medicare Act (PAMA)/Clinical Laboratory Fee Schedule payment data
Medicare program: Medicare Access and CHIP Reauthorization Act (MACRA) implementation
Medicare program: MACRA/small practices
Medicare program: Independent Payment Advisory Board (IPAB) repeal
Medicare program: Community health center fund reauthorization/teaching health center GME
Medicare program: PAMA - Clinical Testing Access and Pricing
Medicare program: PAMA - Misvalued Codes
Medicare program: Pharmacy Benefit Manager (PBM)
Medicare program: Alternate Payment Models
Medicare program: Physician Technical Advisory Committee (PTAC)
Medicare program: Electronic prescribing
Medicare program: Prior authorization/Medicare Part D for covered drugs
Medicare program: Prediabetes and hypertension
Medicare program: Merit-based Incentive Payment System (MIPS)
Medicare program: Regulatory Relief
Medicare program: Electronic Health Records (EHR)
Medicare program: EHR interoperability/data blocking/data exchange
Medicare program: Extenders
Medicare program: Graduate Medical Education (GME)
Medicare program: GME - Residency cap expansion
Medicare program: Telemedicine
Medicare program: Program Integrity
Medicare program: Quality Payment Program (QPP)
Medicare program: Cybersecurity
Medicare program: EHR Certification
Medicare program: Stark self-referral
Medicare program: Episode cost measures
Medicare program: E & M Documentation
Medicare program: Provider Enrollment, Chain, and Ownership System (PECOS)/Medicare Enrollment
Medicare program: Open Payments
Medicare program: Diabetes prevention
Medicare program: Unique Device Identifier (UDI)
Medicaid program: Childrens Health Insurance Program (CHIP) Reauthorization
Medicaid program: Medicaid funding for Puerto Rico and U.S. Virgin Islands
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Medicare Payment Advisory Commission (MedPAC), Health & Human Services - Dept of (HHS), White House Office
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Shannon |
Curtis |
|
|
|
Laura |
Hoffman |
|
|
|
Sandy |
Marks |
|
|
|
Sharon |
McIlrath |
|
|
|
Matthew |
Reid |
|
|
|
Koryn |
Rubin |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
|
Ashley |
McGlone |
|
|
|
Sylvia |
Trujillo |
|
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TAX
16. Specific lobbying issues
Tax Reform - Accounting Methods
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Thomas |
Roberge |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOB
16. Specific lobbying issues
Tobacco products/FDA oversight authority
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Lindsey |
Brill |
|
|
|
George |
Cox |
III |
|
|
Debra |
Cohn |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code TOR
16. Specific lobbying issues
H.R. 1704, Accessible Care by Curbing Excessive lawSuitS (ACCESS) Act of 2017, all provisions
H.R. 1876, Good Samaritan Health Professionals Act of 2017, all provisions
S. 808, Sports Medicine Licensure Clarity Act of 2017, all provisions
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
George |
Cox |
III |
|
|
Paul |
Westfall |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
H.R. 2123, Veterans E-Health and Telemedicine Support (VETS) Act of 2017, all provisions
S. 925, Veterans E-Health and Telemedicine Support (VETS) Act of 2017, all provisions
Scope of Practice
VA Choice program reauthorization
VA Telehealth Services
VA Anywhere to Anywhere Initiative
Tricare access
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Veterans Affairs - Dept of (VA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Richard |
Deem |
|
|
|
Cynthia |
Brown |
|
|
|
Todd |
Askew |
|
|
|
Aiken |
Hackett |
|
|
|
Dana |
Lichtenberg |
|
|
|
Jason |
Marino |
|
|
|
Thomas |
Roberge |
|
|
|
Andrew |
Wankum |
|
|
|
Margaret |
Garikes |
|
|
|
Jason |
Scull |
|
|
|
George |
Cox |
III |
|
|
Sylvia |
Trujillo |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |